Yekeduz, E. Et Al. 2022. Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors. ANTI-CANCER DRUGS , vol.33, no.10 , 1145-1149.

Yekeduz, E., KÖKSOY, E. B., YAZGAN, S. C., KARATAŞ, G., ÇAY ŞENLER, F., UTKAN, G., ... AKBULUT, H.(2022). Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors. ANTI-CANCER DRUGS , vol.33, no.10, 1145-1149.

Yekeduz, EMRE Et Al. "Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors," ANTI-CANCER DRUGS , vol.33, no.10, 1145-1149, 2022

Yekeduz, EMRE Et Al. "Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors." ANTI-CANCER DRUGS , vol.33, no.10, pp.1145-1149, 2022

Yekeduz, E. Et Al. (2022) . "Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors." ANTI-CANCER DRUGS , vol.33, no.10, pp.1145-1149.

@article{article, author={EMRE YEKEDÜZ Et Al. }, title={Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors}, journal={ANTI-CANCER DRUGS}, year=2022, pages={1145-1149} }